eMeasure Title Pregnant women that had HBsAg testing
eMeasure Identifier
(Measure Authoring Tool)
158 eMeasure Version number 2
NQF Number 0608 GUID 3bbfc929-50c8-44b8-8d34-82be75c08a70
Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward OptumInsight
Measure Developer OptumInsight
Endorsed By National Quality Forum
Description
This measure identifies pregnant women who had a HBsAg (hepatitis B) test during their pregnancy.
Copyright
None
Disclaimer
None
Measure Scoring Proportion
Measure Type Process
Stratification
None
Risk Adjustment
None
Rate Aggregation
None
Rationale
The USPSTF found good evidence that universal prenatal screening for HBV infection using HBsAg substantially reduces prenatal transmission of HBV and the subsequent development of chronic HBV infection (USPSTF 2004). The current practice of vaccinating all infants against HBV infection and post-exposure prophylaxis with hepatitis B immune globulin administered at birth to infants of HBV-infected mothers substantially reduces the risk for acquiring HBV infection.
Clinical Recommendation Statement
The U.S. Preventive Services Task Force (USPSTF) strongly recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit (USPSTF 2004). This is a grade A* recommendation from the USPSTF. In addition, the American College of Obstetricians and Gynecologists (ACOG) recommend screening all pregnant women for HBV infection (ACOG 2002).
Improvement Notation
Higher score indicates better quality
Reference
U.S. Preventive Services Task Force. Screening for Hepatitis B Infection: Recommendation Statement. February 2004. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/hepbscr/hepbrs.htm Accessed June 10, 2009
Reference
American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for perinatal care, 5th ed. Elk Grove Village (IL): AAP; Washington, DC: ACOG; 2002.
Definition
None
Guidance
None
Transmission Format
TBD
Initial Patient Population
All female patients aged 12 and older who had a live birth or delivery during the measurement period.
Denominator
Equals Initial Patient Population.
Denominator Exclusions
None
Numerator
Patients who were tested for Hepatitis B surface antigen (HBsAg) during pregnancy within 280 days prior to delivery.
Numerator Exclusions
Not Applicable
Denominator Exceptions
Patients with current or past Hepatitis B infection.
Measure Population
Not Applicable
Measure Observations
Not Applicable
Supplemental Data Elements
For every patient evaluated by this measure also identify payer, race, ethnicity and sex.

Table of Contents


Population criteria

Data criteria (QDM Data Elements)

Reporting Stratification

Supplemental Data Elements




Measure Set
None